Literature DB >> 8138073

Postural control in sitting the SAM system: evaluation of use over three years.

P M Pope1, C E Bowes, E Booth.   

Abstract

The most appropriate posture in which to support the person with severe disability and diverse symptoms as a result of complex pathology remains more a matter of opinion than the result of research. This work reviews some of the studies which have attempted to identify definitive criteria for seating in such cases. Factors relating to measurement and conditions which threaten to invalidate the results of research in this field are highlighted. A description of the Seating and Mobility (SAM) system is given, together with a report of the monitoring of nine children with cerebral palsy using the system for a period of three years. The difficulties inherent in this work are noted and questions for future considerations are raised.

Entities:  

Mesh:

Year:  1994        PMID: 8138073     DOI: 10.1111/j.1469-8749.1994.tb11837.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  3 in total

1.  Powered mobility interventions for very young children with mobility limitations to aid participation and positive development: the EMPoWER evidence synthesis.

Authors:  Nathan Bray; Niina Kolehmainen; Jennifer McAnuff; Louise Tanner; Lorna Tuersley; Fiona Beyer; Aimee Grayston; Dor Wilson; Rhiannon Tudor Edwards; Jane Noyes; Dawn Craig
Journal:  Health Technol Assess       Date:  2020-10       Impact factor: 4.014

2.  Sitting and standing performance in a total population of children with cerebral palsy: a cross-sectional study.

Authors:  Elisabet Rodby-Bousquet; Gunnar Hägglund
Journal:  BMC Musculoskelet Disord       Date:  2010-06-23       Impact factor: 2.362

Review 3.  Tilted seat position for non-ambulant individuals with neurological and neuromuscular impairment: a systematic review.

Authors:  S M Michael; D Porter; T E Pountney
Journal:  Clin Rehabil       Date:  2007-12       Impact factor: 3.477

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.